Our brand new EGFR Multiplex cfDNA Reference Standard Set covers 10 EGFR variants that are implicated in the responsiveness to EGFR-tyrosine kinase inhibitors (EGFR-TKIs) and anti-EGFR monoclonal antibodies. In this new Reference Standard set, we provide variant allelic frequencies of: 5%, 1%, 0.1%, 0% (EGFR Multiplex wild type). The 10 variants include clinically relevant SNPs, insertions and deletions in EGFR and can be used to optimize, validate and routinely monitor assay performance.
Company Info:
Horizon Discovery combines deep scientific experience in translational research with a precision gene-editing platform incorporating rAAV, CRISPR and ZFN technologies. Horizon supplies genetically-defined cell lines, in vivo models, custom cell line generation, molecular reference standards, and contract research services to over 1,000 academic, clinical and biopharmaceutical organizations.
Contact Information:
Horizon Discovery Ltd. 8100 Cambridge Research Park, Waterbeach, Cambridge CB25 9TL
Phone: +44 (0) 1223 976000
Email: info@horizondiscovery.com
